Research Division, Minami Nippon Dairy Co-op Co. Ltd., 5282 Takagi, Miyakonojo, Miyazaki 885-0003, Japan.
Int Immunopharmacol. 2011 Dec;11(12):1976-83. doi: 10.1016/j.intimp.2011.08.007. Epub 2011 Aug 24.
Some probiotics possess immunomodulatory activities and have been used as complementary and alternative medicines. We previously found that 10 lactic acid bacteria (LAB) strains isolated from traditional Mongolian dairy products showed probiotic potential in vitro. In this study, we assessed the immunomodulatory activity of 10 LABs on influenza virus (IFV) infection in relation to their efficacies in IFV-infected mice. In an intranasal IFV infection model in mice, oral administration of boiled Lactobacillus plantarum 06CC2 strain (20mg/mouse), one of the 10 LABs, twice daily for 10 days starting two days before infection was significantly effective in protecting the body weight loss of infected mice, reducing virus yields in the lungs on days 2, 4, and 6 after infection, and prolonging survival times without toxicity. The total numbers of infiltrated cells in the bronchoalveolar lavage fluid (BALF), especially macrophages and neutrophils, were significantly reduced by 06CC2 administration on day 2. On day 2, tumor necrosis factor (TNF)-α production in BALF was also reduced significantly, but interferon-α, interleukin-12, and interferon-γ productions were augmented and natural killer (NK) cell activity was significantly elevated. Furthermore, the gene expressions of interleukin-12 receptor and interferon-γ in Peyer's patches were augmented by 06CC2 administration on day 2. Thus, 06CC2 was suggested to alleviate influenza symptoms in mice in correlation with the augmentation of NK cell activity associated with the enhancement of interferon-α and Th1 cytokine productions through intestinal immunity and the reduction of TNF-α in the early stage of infection.
一些益生菌具有免疫调节活性,已被用作补充和替代医学。我们之前发现,从传统蒙古乳制品中分离出的 10 株乳酸菌(LAB)在体外具有益生菌潜力。在这项研究中,我们评估了 10 株 LAB 对流感病毒(IFV)感染的免疫调节活性与其在 IFV 感染小鼠中的功效的关系。在小鼠鼻腔 IFV 感染模型中,口服煮沸的植物乳杆菌 06CC2 株(20mg/只),这是 10 株 LAB 中的一种,在感染前两天每天两次,共 10 天,可显著保护感染小鼠的体重减轻,减少感染后第 2、4 和 6 天肺部的病毒载量,并延长无毒性的存活时间。06CC2 给药可显著减少第 2 天支气管肺泡灌洗液(BALF)中浸润细胞的总数,尤其是巨噬细胞和中性粒细胞。06CC2 给药还可显著降低 BALF 中的肿瘤坏死因子(TNF)-α产生,但增加干扰素-α、白细胞介素-12 和干扰素-γ的产生,并显著提高自然杀伤(NK)细胞活性。此外,06CC2 给药可在第 2 天增强派伊尔氏斑中的白细胞介素-12 受体和干扰素-γ的基因表达。因此,06CC2 可减轻小鼠的流感症状,与 NK 细胞活性的增强相关,这与通过肠道免疫增强干扰素-α和 Th1 细胞因子的产生以及在感染早期降低 TNF-α有关。